Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07146516 · ClinicalTrials.gov registry record · NA
Retinal Detachment Prevention (Laser Prophylaxis) in Stickler Syndrome (SS)
A NA study of Stickler Syndrome Type 1 and Stickler Syndrome Type 2, sponsored by Helen Keller Eye Research Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 2
- Study locations
NCT07146516 is a NA study of Stickler Syndrome Type 1 and Stickler Syndrome Type 2 that is actively recruiting participants, run by Helen Keller Eye Research Foundation. The registered enrollment target is 500 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT07146516, a NA study of Stickler Syndrome Type 1 and Stickler Syndrome Type 2, is actively recruiting participants, sponsored by Helen Keller Eye Research Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to prospectively document to what extent the OSC/SS prophylactic laser retinopexy procedure works to prevent retinal detachment in SS in children and adults. Researchers will compare the OSC/SS procedure in SS to the natural progression of SS to see to what extent the OSC/SS procedure works to prevent retinal detachment. Participants will: * Have the OSC/SS procedure in one or both eyes * Have eye tests * Have genetic testing for SS as needed * Visit the study center 9 times over 5 years for checkups and tests
Conditions Studied
Interventions
- PROCEDURE Prophylactic (non-invasive) Laser Retinopexy
Study Locations (2)
Alabama
- Retina Specialists of Alabama - Birmingham
Minnesota
- Retina Consultants of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-10-30 |
| Est. Completion | 2035-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07146516
The ClinicalTrials.gov registry entry for NCT07146516 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Helen Keller Eye Research Foundation, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stickler Syndrome Type 1 appearing as the primary indexed condition, and to 1 intervention - of which Prophylactic (non-invasive) Laser Retinopexy is the first listed.
NCT07146516 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Minnesota.
Frequently Asked Questions
What is clinical trial NCT07146516 about?
NCT07146516 is a clinical study titled "Retinal Detachment Prevention (Laser Prophylaxis) in Stickler Syndrome (SS)". The goal of this clinical trial is to prospectively document to what extent the OSC/SS prophylactic laser retinopexy procedure works to prevent retinal detachment in SS in children and adults. Researchers will compare the OSC/SS procedure in SS to the natural progression of SS to see to what extent...
What is the current status of trial NCT07146516?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-10-30. Estimated completion is 2035-12.
What conditions does trial NCT07146516 study?
This clinical trial studies the following conditions: Stickler Syndrome Type 1, Stickler Syndrome Type 2.
What interventions are being tested in trial NCT07146516?
The interventions under investigation include: Prophylactic (non-invasive) Laser Retinopexy (PROCEDURE).
Who is sponsoring clinical trial NCT07146516?
This trial is sponsored by Helen Keller Eye Research Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07146516 being conducted?
This trial has 2 study locations across Alabama, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.